Seroprevalence of herpes simplex virus type 2 antibodies in New Zealand sexual health clinic patients

New Zealand Medical Journal

Volumn 109, Issue 1032, 1996, Pages 402-405

  Perkins, N L ^a   Coughlan, E P ^a   Franklin, R A ^a,c   Reid, M R ^a   Taylor, J ^b  

^a Auckland Sexual Health Service   (New Zealand)

^b WESTMEAD HOSPITAL   (Australia)

^c AUCKLAND CITY HOSPITAL   (New Zealand)

Author keywords

[No Author keywords available]

Indexed keywords

VIRUS ANTIBODY;

ADOLESCENT; ADULT; ARTICLE; BLOOD; CROSS-SECTIONAL STUDY; EPIDEMIOLOGY; FEMALE; GENITAL HERPES; HERPES SIMPLEX VIRUS 2; HUMAN; IMMUNOLOGY; MALE; MIDDLE AGED; NEW ZEALAND; PREVALENCE;

ADOLESCENT; ADULT; ANTIBODIES, VIRAL; CROSS-SECTIONAL STUDIES; FEMALE; HERPES GENITALIS; HERPESVIRUS 2, HUMAN; HUMANS; MALE; MIDDLE AGED; NEW ZEALAND; PREVALENCE; SEROEPIDEMIOLOGIC STUDIES;

EID: 0030601571     PISSN: 00288446     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (16)

1. Johnson RE, Nahmias AJ, Magder LS, et al. A seroepidemic survey of the prevalence of herpes simplex virus type 2 infection in the United State. N Engl J Med 1989; 321: 7-12.
2. Breinig MK, Kingsley LA, Armstrong JA, et al. Epidemiology of genital herpes in Pittsburgh: serologic, sexual and racial correlates of apparent and inapparent herpes simplex infections. J Infect Dis 1990; 162; 299-305.
3. Gibson JJ, Hornung CA, Alexander GR, et al. A cross-sectional study of herpes simplex type 1 and 2 in college students: occurrence and determinants of infection. J Infect Dis 1990; 162: 306-12.
4. Cunningham AL, Lee FK, Ho DWT, et al. Herpes simplex virus type 2 antibody in patients attending antenatal or STD clinics. Med J Aust 1993; 158: 525-8.
5. Mertz GJ. Epidemiology of genital herpes infections Infect Dis Clin North Am 1993; 7; 4: 825-38.
6. Nahmias AJ, Lee FK, Beckman-Nahmias S. Sero-epidemiolgical and sociological patterns of herpes simplex virus infection in the world. Scand J Infect Dis 1990; 60 (Suppl): 19-36.
7. Bassett I, Donovan B, Bodsworth N, et al. Herpes simplex virus type 2 infection of heterosexual men attending a sexual health centre. Med J Aust 1994; 160: 697-700.
8. Oliver L, Wald A, Kim M, et al. Seroprevalence of herpes simplex virus infections in a family medicine clinic. Arch Fam Med (United States) 1995; 4: 228-32.
9. Cowan FM, Johnson AM, Ashley R, et al. Antibody to herpes simplex virus type 2 as serological marker of sexual lifestyle in populations. BMJ 1994; 309: 1325-9.
10. Field PR, Ho DWT, Irving WL, et al. The reliability of serological tests for the diagnosis of genital herpes: a critique. Pathology 1993; 25: 175-9.
11. Dickson NP, Paul C, Skegg DCG, et al. Unlinked anonymous monitoring of HIV prevalence at sexually transmitted disease clinics. NZ Med J 1993; 106: 325-7.
12. Gill ON, Adler MW, Day NE. Monitoring the prevalence of HIV. BMJ 1989; 299: 1295-6.
13. Ho DWT, Field PR, Sjörgren-Jansson E, et al. Indirect ELISA for the detection of HSV-2 specific IgG and IgM antibodies with glycoprotein G (gG-2). J Virol Methods 1992; 36: 249-64
14. Dean AG, Dean JA, Coulombier D, et al. Epi Info Version 6: a word processing, database, and statistics program for epidemiology on microcomputers. Centers for Disease Control and Prevention, Atlanta, Georgia, USA, 1994.
15. Corey L. The current trend in genital herpes. Sex Transm Dis 1994; 21 (Suppl): 538-43.
16. Forsgren M, Skoog E, Jeansson S, et al. Prevalence of antibodies to herpes simplex virus in pregnant women in Stockholm in 1969, 1983 and 1989: implications for STD epidemiology. Int J STD AIDS 1994; 5(2): 113-6.